Jazz Pharmaceuticals plc (JAZZ) › Weighted Average Diluted SharesJazz Pharmaceuticals plc (JAZZ) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2009-12-31: 30.02M2010-12-31: 39.41M2011-12-31: 46.80M2012-12-31: 60.20M2013-12-31: 61.57M2014-12-31: 62.61M2015-12-31: 63.04M2016-12-31: 61.87M2017-12-31: 61.32M2018-12-31: 61.22M2019-12-31: 57.55M2020-12-31: 56.52M2021-12-31: 59.69M2022-12-31: 62.54M2023-12-31: 72.07M2024-12-31: 66.01M2025-12-31: 60.98M60.98M2009-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3160.98M-7.6%2026-02-24From 2025-01-012024-12-3166.01M-8.4%2026-02-24From 2024-01-012023-12-3172.07M+15.2%2026-02-24From 2023-01-012022-12-3162.54M+4.8%2025-02-26From 2022-01-012021-12-3159.69M+5.6%2024-02-28From 2021-01-012020-12-3156.52M-1.8%2023-03-01From 2020-01-012019-12-3157.55M-6.0%2022-03-01From 2019-01-012018-12-3161.22M-0.2%2021-02-23From 2018-01-012017-12-3161.32M-0.9%2020-02-25From 2017-01-012016-12-3161.87M-1.8%2019-02-26From 2016-01-012015-12-3163.04M+0.7%2018-02-27From 2015-01-012014-12-3162.61M+1.7%2017-02-28From 2014-01-012013-12-3161.57M+2.3%2016-02-23From 2013-01-012012-12-3160.20M+28.6%2015-02-24From 2012-01-012011-12-3146.80M+18.7%2014-02-25From 2011-01-012010-12-3139.41M+31.3%2013-02-26From 2010-01-012009-12-3130.02M—2012-02-28From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)